| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $0 ) |
| | 2026 | 2024 | MYRIEL, INC. | 1000 WESTGATE DR STE 9150E | SAINT PAUL | MN | 55114-8612 | RAMSEY | USA | R41NS134497 | Prodrugs of potent and selective protease inhibitors as tauopathy therapeutics | 000 | 2 | NIH | 3/2/2026 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $349,992 ) |
| | 2024 | 2024 | MYRIEL, INC. | 1000 WESTGATE DR STE 9150E | SAINT PAUL | MN | 55114-8612 | RAMSEY | USA | R41NS134497 | Prodrugs of potent and selective protease inhibitors as tauopathy therapeutics | 001 | 2 | NIH | 8/28/2024 | $349,992 |
| | 2024 | 2023 | MYRIEL, INC. | 1010 DALE ST N | SAINT PAUL | MN | 55117-5603 | RAMSEY | USA | R41NS134497 | Prodrugs of potent and selective protease inhibitors as tauopathy therapeutics | 000 | 1 | NIH | 11/28/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $349,992 ) |
| | 2023 | 2023 | MYRIEL, INC. | 1010 DALE ST N | SAINT PAUL | MN | 55117-5603 | RAMSEY | USA | R41NS134497 | Prodrugs of potent and selective protease inhibitors as tauopathy therapeutics | 000 | 1 | NIH | 9/19/2023 | $349,992 |
|
|
